Medicare Enrolled

Dr. Kuldip Banwait, M.D.

Gastroenterology · Amarillo, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
800 QUAIL CREEK DR, Amarillo, TX 79124
8063549400
In practice since 2006 (19 years)
NPI: 1699877670 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Banwait from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Banwait? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Banwait

Dr. Kuldip Banwait is a gastroenterology in Amarillo, TX, with 19 years in practice. Based on federal Medicare data, Dr. Banwait performed 1,278 Medicare services across 1,170 unique beneficiaries.

Between the years covered by Open Payments, Dr. Banwait received a total of $11,740 from 36 pharmaceutical and/or device companies across 327 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Banwait is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 16% volume in TX$ $11,740 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,278
Medicare services
Top 16% in TX for gastroenterology
1,170
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~67 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
New patient office visit (45-59 min)191$107$300
Upper GI endoscopy with biopsy181$76$1,080
Office visit, established patient (20-29 min)154$59$150
Removal of polyps or growths of large bowel using an endoscope with mechanical snare136$188$1,756
Colonoscopy with biopsy123$103$1,596
Hospital follow-up visit, moderate complexity118$59$200
Prostate cancer screening; digital rectal examination112$7$51
Initial hospital admission, high complexity75$131$327
Office visit, established patient (30-39 min)59$91$200
Diagnostic exam of large bowel using a flexible endoscope51$107$1,376
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope46$87$1,012
Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm17$110$1,701
Imaging of digestive tract done from the inside of the digestive tract15$566$3,134
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,740
Total received (2018-2024)
Avg $1,677/year across 7 years
Top 17% in TX for gastroenterology
36
Companies
327
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,162 (52.5%)
Other
Charitable contributions, space rental, and other categories
$5,546 (47.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$32 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,281
2023
$1,401
2022
$583
2021
$6,164
2020
$411
2019
$795
2018
$1,105

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$5,546
AbbVie Inc.
$1,301
Takeda Pharmaceuticals U.S.A., Inc.
$916
AbbVie, Inc.
$619
ABBVIE INC.
$539
PFIZER INC.
$376
Gilead Sciences, Inc.
$333
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$287
Intercept Pharmaceuticals, Inc.
$237
Regeneron Healthcare Solutions, Inc.
$186
Madrigal Pharmaceuticals
$147
Ipsen Biopharmaceuticals, Inc
$137
Boston Scientific Corporation
$114
Synergy Pharmaceuticals Inc
$86
GENZYME CORPORATION
$84
Daiichi Sankyo Inc.
$77
Ardelyx, Inc.
$73
INTERCEPT PHARMACEUTICALS, INC.
$73
Allergan Inc.
$69
BOSTON SCIENTIFIC CORPORATION
$67
Mauna Kea Technologies, Inc.
$67
Janssen Biotech, Inc.
$66
Ferring Pharmaceuticals Inc.
$60
Merck Sharp & Dohme Corporation
$40
Phathom Pharmaceuticals, Inc.
$32
QOL Medical, LLC
$30
Olympus America Inc.
$28
Amgen Inc.
$24
Sandoz Inc.
$21
RedHill Biopharma Inc.
$17
Covidien LP
$17
EVOKE PHARMA, INC.
$16
Celgene Corporation
$16
UCB, Inc.
$15
Evoke Pharma, Inc.
$13
Alfasigma USA, Inc.
$12
Top 3 companies account for 66.1% of total payments
Associated products mentioned in payments ›
AVSOLA · Amitiza · Bylvay · CAPTIVATOR COLD · CLENPIQ · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · Entyvio · GATTEX · GIMOTI · HUMIRA · HYRIMOZ · Humira · IBSRELA · INJECTAFER · IQIRVO · LINZESS · MAVYRET · MOTEGRITY · MOVIPREP · Mavyret · Motegrity · NINLARO · OCALIVA · ONIVYDE · Olympus EndoTherapy Accessories · PLENVU · REBYOTA · RESMETIROM · RESOLUTION CLIP · REZDIFFRA · RINVOQ · SKYRIZI · SPYGLASS · STELARA · SUCRAID · Smart Pill · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · UCERIS TABLETS · VELSIPITY · VOQUEZNA · WALLFLEX · XELJANZ · XIFAXAN · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (52%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $919 per 100 Medicare services performed
Looking for a gastroenterology in Amarillo?
Compare gastroenterologys in the Amarillo area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
12
Per 100K population
10.3
County median income
$50,448
Nearest hospital
QUAIL CREEK SURGICAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Banwait is a clinical cardiology specialist, with above-average Medicare volume (top 16% in TX), and high industry engagement (low-engagement, top 17%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Banwait experienced with new patient office visit (45-59 min)?
Based on Medicare claims data, Dr. Banwait performed 191 new patient office visit (45-59 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Banwait receive payments from pharmaceutical companies?
Yes. Dr. Banwait received a total of $11,740 from 36 companies across 327 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Banwait's costs compare to other gastroenterologys in Amarillo?
Dr. Banwait's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Banwait) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →